159 related articles for article (PubMed ID: 8222746)
1. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.
Arnes E; Dibb WL
Curr Med Res Opin; 1993; 13(3):182-6. PubMed ID: 8222746
[TBL] [Abstract][Full Text] [Related]
2. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
Dohar JE; Roland P; Wall GM; McLean C; Stroman DW
Curr Med Res Opin; 2009 Feb; 25(2):287-91. PubMed ID: 19192973
[TBL] [Abstract][Full Text] [Related]
3. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
Roland PS; Pien FD; Schultz CC; Henry DC; Conroy PJ; Wall GM; Garadi R; Dupre SJ; Potts SL; Hogg LG; Stroman DW;
Curr Med Res Opin; 2004 Aug; 20(8):1175-83. PubMed ID: 15324520
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
Drehobl M; Guerrero JL; Lacarte PR; Goldstein G; Mata FS; Luber S
Curr Med Res Opin; 2008 Dec; 24(12):3531-42. PubMed ID: 19032135
[TBL] [Abstract][Full Text] [Related]
6. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
Cantrell HF; Lombardy EE; Duncanson FP; Katz E; Barone JS
South Med J; 2004 May; 97(5):465-71. PubMed ID: 15180022
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis.
Wadsten CJ; Bertilsson CA; Sieradzki H; Edström S
Arch Otorhinolaryngol; 1985; 242(2):135-9. PubMed ID: 2415098
[TBL] [Abstract][Full Text] [Related]
8. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
9. A clinical comparison of hydrocortisone butyrate with oxytetracycline/hydrocortisone acetate-polymyxin B in the local treatment of acute external otitis.
Ruth M; Ekström T; Aberg B; Edström S
Eur Arch Otorhinolaryngol; 1990; 247(2):77-80. PubMed ID: 2156538
[TBL] [Abstract][Full Text] [Related]
10. The use of otic powder in the treatment of acute external otitis.
Goldenberg D; Golz A; Netzer A; Joachims HZ
Am J Otolaryngol; 2002; 23(3):142-7. PubMed ID: 12019482
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of two anti-bacterial/anti-inflammatory formulations (Auricularum otic powder and Dex-Otic drops) in the medical treatment of otitis externa.
Yaniv E; Shevro J; Nageris B; Lapidot M; Hadar T; Cahani B; Zegerman C
Curr Med Res Opin; 2002; 18(8):520-2. PubMed ID: 12564664
[TBL] [Abstract][Full Text] [Related]
12. A group III steroid solution without antibiotic components: an effective cure for external otitis.
Emgård P; Hellström S
J Laryngol Otol; 2005 May; 119(5):342-7. PubMed ID: 15949095
[TBL] [Abstract][Full Text] [Related]
13. External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics.
Emgård P; Hellström S; Holm S
Acta Otolaryngol; 2005 Apr; 125(4):346-52. PubMed ID: 15823803
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
Tempera G; Mangiafico A; Genovese C; Giudice E; Mastrojeni S; Nicolosi D; Ferneri PM
Int J Immunopathol Pharmacol; 2009; 22(2):299-302. PubMed ID: 19505383
[TBL] [Abstract][Full Text] [Related]
15. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension.
Miró N
Otolaryngol Head Neck Surg; 2000 Nov; 123(5):617-23. PubMed ID: 11077352
[TBL] [Abstract][Full Text] [Related]
16. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
Roland PS; Belcher BP; Bettis R; Makabale RL; Conroy PJ; Wall GM; Dupre S; Potts S; Hogg G; Weber K;
Am J Otolaryngol; 2008; 29(4):255-61. PubMed ID: 18598837
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature.
Wall GM; Stroman DW; Roland PS; Dohar J
Pediatr Infect Dis J; 2009 Feb; 28(2):141-4. PubMed ID: 19116600
[TBL] [Abstract][Full Text] [Related]
18. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent.
Neher A; Nagl M; Appenroth E; Gstöttner M; Wischatta M; Reisigl F; Schindler M; Ulmer H; Stephan K
Laryngoscope; 2004 May; 114(5):850-4. PubMed ID: 15126742
[TBL] [Abstract][Full Text] [Related]
19. Acute otitis externa: an update.
Schaefer P; Baugh RF
Am Fam Physician; 2012 Dec; 86(11):1055-61. PubMed ID: 23198673
[TBL] [Abstract][Full Text] [Related]
20. Ofloxacin otic solution for treatment of otitis externa in children and adults.
Jones RN; Milazzo J; Seidlin M
Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1193-200. PubMed ID: 9366699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
